Feng M H, Chan S L, Xiang Y, Huber C P, Lim C
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.
Protein Eng. 1996 Nov;9(11):977-86. doi: 10.1093/protein/9.11.977.
Two binding modes of the isobutyl-NH-Eps-Leu-Pro inhibitor to cathepsin B have been proposed. Molecular docking using an empirical force field was carried out to distinguish between the two modes. The search began with manual docking, followed by random perturbations of the docking conformation and cycles of Monte Carlo minimization. Finally, molecular dynamics was carried out for the most favorable docking conformations. The present calculations predict that the isobutyl-NH-Eps-Leu-Pro inhibitor preferentially binds to the S' rather than the S subsites of cathepsin B. The S' binding mode prediction is supported by the X-ray crystal structure of cathepsin B bound to a closely related ethyl-O-Eps-Ile-Pro inhibitor, which was found to bind in the S'subsite with the C-terminal epoxy ring carbon making a covalent bond to the sulfur atom of Cys29. This agreement, in turn, validates our docking strategy. Furthermore, the calculations provide evidence that the dominant contribution to the total stabilization energy of the enzyme-inhibitor complex stems from the strong electrostatic interaction between the negatively charged C-terminal carboxylate group of the ligand and the positively charged imidazolium rings of His110 and His111. The latter are stabilized and held in an optimal orientation for interactions with the C-terminal end of the ligand through a salt bridge between the side chains of His110 and Asp22. By comparison with the crystal structure, some insight into the specificity of the epoxyldipeptide family towards cathepsin B inhibition has been extracted. Both the characteristics of the enzyme (e.g. subsite size and hydrophobicity) as well as the nature of the inhibitor influence the selectivity of an inhibitor towards an enzyme.
已提出异丁基 - NH - Eps - Leu - Pro抑制剂与组织蛋白酶B的两种结合模式。使用经验力场进行分子对接以区分这两种模式。搜索从手动对接开始,接着是对接构象的随机扰动和蒙特卡罗最小化循环。最后,对最有利的对接构象进行分子动力学模拟。目前的计算预测,异丁基 - NH - Eps - Leu - Pro抑制剂优先结合组织蛋白酶B的S'亚位点而非S亚位点。与组织蛋白酶B结合的密切相关的乙基 - O - Eps - Ile - Pro抑制剂的X射线晶体结构支持了S'结合模式的预测,发现该抑制剂在S'亚位点结合,其C末端环氧环碳与Cys29的硫原子形成共价键。反过来,这种一致性验证了我们的对接策略。此外,计算结果表明,酶 - 抑制剂复合物总稳定能的主要贡献源于配体带负电荷 的C末端羧酸盐基团与His110和His111带正电荷的咪唑环之间的强静电相互作用。后者通过His110和Asp22侧链之间的盐桥得以稳定,并保持在与配体C末端相互作用的最佳取向。通过与晶体结构比较,已获得了一些关于环氧二肽家族对组织蛋白酶B抑制特异性的见解。酶的特性(如亚位点大小和疏水性)以及抑制剂的性质都会影响抑制剂对酶的选择性。